IP Library › Granted Patent US 7,771,470
Granted Patent B2
US 7,771,470 · App. 11/381,891 · Granted Aug 10, 2010

Ophthalmic apparatuses and methods

Assignee: Key Medical Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,771,470
App. No.
11/381,891
Granted
Aug 10, 2010
Kind
B2
Abstract

Blue light blocking chromophore (BLBC) ophthalmic devices are disclosed. In an embodiment, BLBC is relatively concentrated in the device center gradually decreasing to the device edge to create a BLBC gradient.

Claims (12)

1. A method for making a polymeric ophthalmic device intraocular lens (IOL), the IOL having a lens edge and a lens center and a concentration gradient of a polymer additive, the method comprising the steps of:

providing at least a polymer core, the core having a first concentration of the additive and being adapted to comprise at least part of the ophthalmic device;

suspending the core in an ophthalmic device a monomer solution comprising monomer and a second concentration of the additive;

reacting the monomer solution with the polymer core to create the at least part of the ophthalmic device having a concentration gradient of the polymer-modifying additive, wherein the first concentration of additive is higher than the second concentration of additive so that the additive concentration gradient of the lens increases from lens edge to lens center.

2. A method according to claim 1 wherein the additive is a chromophore.

3. A method according to claim 1 wherein the additive is a BLBC.

4. A method for making a polymeric ophthalmic device intraocular lens (IOL), the IOL having a lens edge and a lens center and a concentration gradient of a polymer additive, the method comprising the steps of:

providing at least a polymer core, the core having a first concentration of the additive and being adapted to comprise at least part of the ophthalmic device;

suspending the core in an ophthalmic device a monomer solution comprising monomer and a second concentration of the additive;

reacting the monomer solution with the polymer core to create the at least part of the ophthalmic device having a concentration gradient of the polymer-modifying additive, wherein the first concentration of additive is lower than the second concentration of additive so that the additive concentration gradient decreases from the edge of the lens to the center of the lens.

5. A method according to claim 4 wherein the additive is a chromophore.

6. A method according to claim 4 wherein the additive is a BLBC.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2006
From: MENTAK, KHALID
To: KEY MEDICAL TECHNOLOGIES, INC.
Reel/Frame 018269/0224 →
Continuity (2)
Provisional Application 6067791700 · May 5, 2005
Related Publication 20070004852A1 · Jan 4, 2007